Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation

Abstract Objective: In this study, attempt has been focused to prepare a nanoemulsion (NE) gel for topical delivery of amphotericin B (AmB) for enhanced as well as sustained skin permeation, in vitro antifungal activity and in vivo toxicity assessment. Materials and methods: A series of NE were prepared using sefsol-218 oil, Tween 80 and Transcutol-P by slow spontaneous titration method. Carbopol gel (0.5% w/w) was prepared containing 0.1% w/w AmB. Furthermore, NE gel (AmB-NE gel) was characterized for size, charge, pH, rheological behavior, drug release profile, skin permeability, hemolytic studies and ex vivo rat skin interaction with rat skin using differential scanning calorimeter. The drug permeability and skin irritation ability were examined with confocal laser scanning microscopy and Draize test, respectively. The in vitro antifungal activity was investigated against three fungal strains using the well agar diffusion method. Histopathological assessment was performed in rats to investigate their toxicological potential. Results and discussion: The AmB-NE gel (18.09 ± 0.6 µg/cm2/h) and NE (15.74 ± 0.4 µg/cm2/h) demonstrated the highest skin percutaneous permeation flux rate as compared to drug solution (4.59 ± 0.01 µg/cm2/h) suggesting better alternative to painful and nephrotoxic intravenous administration. Hemolytic and histopathological results revealed safe delivery of the drug. Based on combined results, NE and AmB-NE gel could be considered as an efficient, stable and safe carrier for enhanced and sustained topical delivery for AmB in local skin fungal infection. Conclusion: Topical delivery of AmB is suitable delivery system in NE gel carrier for skin fungal infection.

[1]  K. Creek,et al.  Evaluation of transdermal penetration enhancers using a novel skin alternative. , 1997, Journal of pharmaceutical sciences.

[2]  P A Bowser,et al.  Isolation, barrier properties and lipid analysis of stratum compactum, a discrete region of the stratum corneum , 1985, The British journal of dermatology.

[3]  A. Hussain,et al.  Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B , 2015, Drug development and industrial pharmacy.

[4]  P. Elias,et al.  The Stratum Corneum Revisited , 1996, The Journal of dermatology.

[5]  Puneet Utreja,et al.  Localized delivery of paclitaxel using elastic liposomes: Formulation development and evaluation , 2011, Drug delivery.

[6]  Huibi Xu,et al.  Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[7]  L. H. Reddy,et al.  Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin. , 2001, Indian journal of experimental biology.

[8]  Natas˘a S˘kalko,et al.  Liposomes with Metronidazole for Topical Use: The Choice of Preparation Method and Vehicle , 1998 .

[9]  O Sonneville-Aubrun,et al.  Nanoemulsions: a new vehicle for skincare products. , 2004, Advances in colloid and interface science.

[10]  J. Irache,et al.  Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity , 1997 .

[11]  Thalita Pedroni Formariz,et al.  Microemulsoes e fases liquidas cristalinas como sistemas de liberacao de farmacos , 2005 .

[12]  N. Jain,et al.  Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. , 2013, Life sciences.

[13]  Kamalinder K. Singh,et al.  Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A , 2008, AAPS PharmSciTech.

[14]  M. C. Popescu,et al.  Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. , 1992, Biochimica et biophysica acta.

[15]  L. Chan,et al.  Characterization of spreadability of nonaqueous ethylcellulose gel matrices using dynamic contact angle. , 2008, Journal of pharmaceutical sciences.

[16]  Manohar Balaraman,et al.  In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[17]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[18]  John H. Draize,et al.  METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .

[19]  C. Santilli,et al.  Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine. , 2006, Colloids and surfaces. B, Biointerfaces.

[20]  V. Carelli,et al.  Effect of vehicles on yohimbine permeation across excised hairless mouse skin. , 1998, Pharmaceutica acta Helvetiae.

[21]  E. W. Kellogg,et al.  Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. , 1977, The Journal of biological chemistry.

[22]  A. Dinda,et al.  Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. , 2006, Colloids and surfaces. B, Biointerfaces.

[23]  B. Guglielmo,et al.  Lipid formulations of amphotericin B: clinical efficacy and toxicities. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Hong Yuan,et al.  Preparation and characteristics of monostearin nanostructured lipid carriers. , 2006, International journal of pharmaceutics.

[25]  M. Basri,et al.  Formation and stability of new palm-based nanoemulsions , 2008 .

[26]  Tg Repeated Dose Dermal Toxicity: 21/28-Day Study (OECD TG 410) , 2018, OECD Series on Testing and Assessment.

[27]  M. Kleinberg What is the current and future status of conventional amphotericin B? , 2006, International journal of antimicrobial agents.

[28]  H. Fukui,et al.  Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. , 2003, International journal of pharmaceutics.

[29]  Sang-Chul Shin,et al.  Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  D. Attwood,et al.  Phase studies on oil-in-water phospholipid microemulsions , 1992 .

[31]  N. K. Jain,et al.  Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[32]  D. Plumb Veterinary Drug Handbook , 1999 .

[33]  H. Fukui,et al.  Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). , 2003, International journal of pharmaceutics.

[34]  Amit Kumar,et al.  Role of membrane sialic acid and glycophorin protein in thorium induced aggregation and hemolysis of human erythrocytes. , 2010, Biochimie.

[35]  M. Glavas-Dodov,et al.  The effects of lyophilization on the stability of liposomes containing 5-FU. , 2005, International journal of pharmaceutics.

[36]  O. Kayser,et al.  Amphotericin B , 2005, Applied Microbiology and Biotechnology.

[37]  B. Röder,et al.  Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[38]  S. Zellmer,et al.  Interaction of phosphatidylcholine liposomes with the human stratum corneum. , 1995, Biochimica et biophysica acta.

[39]  T. Dutta,et al.  Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[40]  R. Snyderman,et al.  Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorphonuclear leukocytes is disrupted by phorbol esters. , 1987, The Journal of biological chemistry.

[41]  R. Potts,et al.  Lipid thermotropic transitions in human stratum corneum. , 1986, The Journal of investigative dermatology.

[42]  H. Fukui,et al.  A novel delivery system for amphotericin B with lipid nano-sphere (LNS). , 2003, International journal of pharmaceutics.

[43]  A. Hussain,et al.  Nanocarrier-based topical drug delivery for an antifungal drug , 2014, Drug development and industrial pharmacy.

[44]  M. Rizwan,et al.  Nanoemulsion Components Screening and Selection: a Technical Note , 2009, AAPS PharmSciTech.

[45]  Liu Wei-na,et al.  Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. , 2012, International journal of pharmaceutics.